homevideos Newsretail News

It is a win win deal for HUL and GSK says, Milind Sarwate of Increate Value Advisors

videos | Dec 3, 2018 10:44 PM IST

It is a win-win deal for HUL and GSK says, Milind Sarwate of Increate Value Advisors

Follow real-time updates on Union Budget 2023Catch exclusive videos on Union Budget 2023 from CNBC-TV18
Unilever is to buy GlaxoSmithKline's Horlicks nutrition business for $3.8 billion, boosting the Anglo-Dutch group's position in India with the addition of the malted drink.

Recommended Articles

View All

The deal, announced on Monday, increases the consumer goods giant's footprint in one the world's fastest-growing economies and marks a notable addition to the portfolio by outgoing chief executive Paul Polman, who steps down in January.
Sunil Alagh, founder and chairman, SKA Advisors; Milind Sarwate, founder and CEO, Increate Value Advisors and Girish Vanvari, tax expert.
Milind Sarwate said, “It is a good win-win deal for both HUL and GSK, simply because the reasons for this decision from both sides are different."
GSK is doing it more for reorganising their global strategic portfolio whereas HUL is doing it to add to its India’s presence and build complementarity into its health portfolio, Sarwate said.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers